SPP1 and neoplasm: As evidenced by a greater abundance of pre-existing literature on the effects of SPP1 in tumor progression as well as a potential therapeutic target [13,19,26,27], combined with a generally higher global prevalence of cancer in four particular human tissues, breast, prostate, renal and skin, we specifically focused on studying the above effects in these types of cancer.